This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1981.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981
Title: Manfred Stahnke: Innovator in Pharmaceutical Chemistry
Introduction
Manfred Stahnke is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes and formulations. His work has led to advancements that are crucial in the development of new medications.
Latest Patents
Stahnke holds a patent for a process related to the preparation of novel 17.alpha.-(3-iodobenzoyloxy)-9.alpha.-chloro-4-pregnene-3,20-diones and the D-homo homologs thereof. This patent is essential for the synthesis of compounds that have potential therapeutic applications.
Career Highlights
Throughout his career, Manfred Stahnke has been associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His work at Schering has allowed him to focus on innovative solutions in drug development and formulation.
Collaborations
Stahnke has collaborated with esteemed colleagues such as Ulrich Kerb and Rudolf Wiechert. These partnerships have fostered a collaborative environment that enhances research and development efforts in the pharmaceutical sector.
Conclusion
Manfred Stahnke's contributions to pharmaceutical chemistry through his patent and collaborations highlight his role as an influential inventor. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile